# v3.16

## Related releases
This data release requires database changes and only work with the following releases
https://github.com/oncokb/oncokb/releases/tag/v3.10.0
https://github.com/oncokb/oncokb-public/releases/tag/3.8.0

## Data changes
Gene:
BCL3 Gene Added
BRD3 Gene Added
BRSK1 Gene Added
MKI67 Gene Added

Alteration:
BCL3 IGH-BCL3 Fusion Added
BRCA2 T2515I, Oncogenicity Updated
	 New: Inconclusive
	 Old: Likely
TP53 R175H, Mutation Effect Description Updated
TP53 P322R, Mutation Effect Description Updated
TP53 H214R, Mutation Effect Description Updated
TP53 S121F, Mutation Effect Description Updated
TP53 H214Q, Mutation Effect Description Updated
TP53 K291E, Mutation Effect Description Updated
TP53 K292T, Mutation Effect Description Updated
TP53 Q144R, Mutation Effect Description Updated
TP53 I162M, Oncogenicity Updated
TP53 R290G, Mutation Effect Description Updated
TP53 H214R, Oncogenicity Updated

Evidence:
BRAF V600E, All Solid Tumors {excluding Colorectal Cancer} Added
CALR Oncogenic Mutations, Myeloproliferative Neoplasms, Diagnostic Summary Updated
ERBB2 Oncogenic Mutations, Non-Small Cell Lung Cancer, Tumor Type Summary Updated
ERBB2 Oncogenic Mutations, Non-Small Cell Lung Cancer, Trastuzumab Deruxtecan 1 Updated
FGFR1 Fusions, Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of  PDGFRA/PDGFRB or FGFR1 or with PCM1-JAK2, Pemigatinib 1 Added
JAK2 Oncogenic Mutations, Myeloproliferative Neoplasms, Diagnostic Summary Updated
JAK2 Oncogenic Mutations, Essential Thrombocythemia, Tumor Type Summary Updated
JAK2 Oncogenic Mutations, Primary Myelofibrosis, Tumor Type Summary Updated

